|
GB9619757D0
(en)
*
|
1996-09-21 |
1996-11-06 |
Knoll Ag |
Chemical process
|
|
JP2000080047A
(ja)
*
|
1998-06-30 |
2000-03-21 |
Takeda Chem Ind Ltd |
医 薬
|
|
AR019727A1
(es)
*
|
1998-06-30 |
2002-03-13 |
Takeda Chemical Industries Ltd |
Composicion farmaceutica
|
|
US6339106B1
(en)
|
1999-08-11 |
2002-01-15 |
Sepracor, Inc. |
Methods and compositions for the treatment and prevention of sexual dysfunction
|
|
US6331571B1
(en)
|
1998-08-24 |
2001-12-18 |
Sepracor, Inc. |
Methods of treating and preventing attention deficit disorders
|
|
US6974838B2
(en)
*
|
1998-08-24 |
2005-12-13 |
Sepracor Inc. |
Methods of treating or preventing pain using sibutramine metabolites
|
|
US6476078B2
(en)
*
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
|
CZ20011629A3
(cs)
*
|
1998-11-12 |
2001-12-12 |
Smithkline Beecham Plc |
Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
|
|
AR023699A1
(es)
*
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Corp |
Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
|
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
|
US6696495B2
(en)
|
1998-12-02 |
2004-02-24 |
Snowden Pharmaceuticals, Llc |
Treatment of disorders secondary to organic impairments
|
|
US6323242B1
(en)
|
1998-12-02 |
2001-11-27 |
Peter Sterling Mueller |
Treatment of disorders secondary to organic impairments
|
|
US6552087B1
(en)
|
1999-03-19 |
2003-04-22 |
Abbott Gmbh & Co. Kg |
Therapeutic agent comprising (+)-sibutramine
|
|
US6680344B1
(en)
|
1999-06-01 |
2004-01-20 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
WO2000072810A1
(en)
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using sulfonyl thyromimetic compounds
|
|
US6723717B1
(en)
|
1999-06-01 |
2004-04-20 |
The University Of Texas Southwestern Medical Center |
Sulfur-containing thyroxane derivatives and their use as hair growth promotors
|
|
GB9914744D0
(en)
*
|
1999-06-24 |
1999-08-25 |
Knoll Ag |
Therapeutic agents
|
|
US6399826B1
(en)
|
1999-08-11 |
2002-06-04 |
Sepracor Inc. |
Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
|
|
WO2002083631A1
(en)
|
2001-04-13 |
2002-10-24 |
Sepracor Inc. |
Methods of preparing didesmethylsibutramine and other sibutramine derivatives
|
|
US8911781B2
(en)
|
2002-06-17 |
2014-12-16 |
Inventia Healthcare Private Limited |
Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
|
|
NZ538966A
(en)
*
|
2002-10-05 |
2006-11-30 |
Hanmi Pharm |
Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
|
|
US20050131074A1
(en)
*
|
2003-08-04 |
2005-06-16 |
Beckman Kristen M. |
Methods for treating metabolic syndrome
|
|
PE20050335A1
(es)
*
|
2003-08-07 |
2005-06-01 |
Sb Pharmco Inc |
Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion
|
|
GB0318824D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Glaxo Group Ltd |
Novel composition
|
|
CA2540225C
(en)
*
|
2003-10-31 |
2012-03-06 |
Takeda Pharmaceutical Company Limited |
Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
|
|
KR100627687B1
(ko)
*
|
2005-04-20 |
2006-09-25 |
주식회사 씨티씨바이오 |
시부트라민 유리염기 함유 조성물 및 이의 제조방법
|
|
BRPI0706365A2
(pt)
|
2006-01-06 |
2011-03-22 |
Sepracor Inc |
Cicloalquilaminas como inibidores da recaptação de monoamina
|
|
CA2663254C
(en)
|
2006-09-15 |
2016-04-19 |
Reviva Pharmaceuticals, Inc. |
Synthesis, methods of using, and compositions of cycloalkylmethylamines
|
|
KR100812538B1
(ko)
*
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
|
KR20080046601A
(ko)
*
|
2006-11-22 |
2008-05-27 |
에스케이케미칼주식회사 |
보관안정성이 우수한 시부트라민 함유 포접복합체
|
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
US9237864B2
(en)
|
2009-07-02 |
2016-01-19 |
Dexcom, Inc. |
Analyte sensors and methods of manufacturing same
|
|
WO2012003501A2
(en)
|
2010-07-02 |
2012-01-05 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
|
|
ES2711526T3
(es)
|
2010-08-13 |
2019-05-06 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
US9238625B2
(en)
|
2011-12-30 |
2016-01-19 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
EP2819688A4
(en)
|
2012-02-15 |
2015-10-28 |
Aileron Therapeutics Inc |
TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
|
|
WO2014071241A1
(en)
|
2012-11-01 |
2014-05-08 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
|
EP3197478A4
(en)
|
2014-09-24 |
2018-05-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|